The raw feed
Latest filings
Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.
| Date | Company | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | BRNS Vaccitech plc | Joseph Scheeren director | DDisposition to issuer Share Option (Right to Buy)derivative | -20,174 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Anne M. Phillips director | DDisposition to issuer Ordinary Shares | -3,000 | - | - | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Anne M. Phillips director | DDisposition to issuer Share Option (Right to Buy)derivative | -34,328 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Anne M. Phillips director | DDisposition to issuer Share Option (Right to Buy)derivative | -18,604 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Anne M. Phillips director | DDisposition to issuer Share Option (Right to Buy)derivative | -19,197 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Anne M. Phillips director | DDisposition to issuer Share Option (Right to Buy)derivative | -19,516 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Anne M. Phillips director | DDisposition to issuer Share Option (Right to Buy)derivative | -20,174 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Pierre A. Morgon director | DDisposition to issuer Ordinary Shares | -10,506 | - | - | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Pierre A. Morgon director | DDisposition to issuer Share Option (Right to Buy)derivative | -20,394 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Pierre A. Morgon director | DDisposition to issuer Share Option (Right to Buy)derivative | -34,328 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Pierre A. Morgon director | DDisposition to issuer Share Option (Right to Buy)derivative | -18,604 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Pierre A. Morgon director | DDisposition to issuer Share Option (Right to Buy)derivative | -19,197 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Pierre A. Morgon director | DDisposition to issuer Share Option (Right to Buy)derivative | -19,516 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Pierre A. Morgon director | DDisposition to issuer Share Option (Right to Buy)derivative | -20,174 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Leon Hooftman Chief Medical Officer | DDisposition to issuer Ordinary Shares | -361,530 | - | - | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Leon Hooftman Chief Medical Officer | DDisposition to issuer Share Option (Right to Buy)derivative | -195,166 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Leon Hooftman Chief Medical Officer | DDisposition to issuer Share Option (Right to Buy)derivative | -140,000 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Alex Hammacher director | DDisposition to issuer Ordinary Shares | -3,000 | - | - | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Alex Hammacher director | DDisposition to issuer Share Option (Right to Buy)derivative | -34,328 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Alex Hammacher director | DDisposition to issuer Share Option (Right to Buy)derivative | -18,604 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Alex Hammacher director | DDisposition to issuer Share Option (Right to Buy)derivative | -19,197 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Alex Hammacher director | DDisposition to issuer Share Option (Right to Buy)derivative | -19,516 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Alex Hammacher director | DDisposition to issuer Share Option (Right to Buy)derivative | -20,174 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | William Enright Chief Executive Officer | DDisposition to issuer Ordinary Sharesindirect: By Trust | -728,454 | - | - | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | William Enright Chief Executive Officer | DDisposition to issuer Ordinary Sharesindirect: By Trust | -514,923 | - | - | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | William Enright Chief Executive Officer | DDisposition to issuer Share Option (Right to Buy)derivative | -176,130 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | William Enright Chief Executive Officer | DDisposition to issuer Share Option (Right to Buy)derivative | -359,605 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | William Enright Chief Executive Officer | DDisposition to issuer Share Option (Right to Buy)derivative | -440,000 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | William Enright Chief Executive Officer | DDisposition to issuer Share Option (Right to Buy)derivative | -443,981 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | William Enright Chief Executive Officer | DDisposition to issuer Share Option (Right to Buy)derivative | -600,000 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Karen A Dawes director | DDisposition to issuer Ordinary Shares | -1,700 | - | - | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Karen A Dawes director | DDisposition to issuer Share Option (Right to Buy)derivative | -34,328 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Karen A Dawes director | DDisposition to issuer Share Option (Right to Buy)derivative | -18,604 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Karen A Dawes director | DDisposition to issuer Share Option (Right to Buy)derivative | -19,197 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Karen A Dawes director | DDisposition to issuer Share Option (Right to Buy)derivative | -19,516 | $0.00 | $0 | 0 | 36 d ago |
| Sep 9, 2026 | BRNS Vaccitech plc | Karen A Dawes director | DDisposition to issuer Share Option (Right to Buy)derivative | -20,174 | $0.00 | $0 | 0 | 36 d ago |
| Sep 4, 2026 | CBSH COMMERCE BANCSHARES INC /MO/ | Jennifer B Upton Senior Vice President | DDisposition to issuer Common Stock | -143 | $58.51 | $8,367 | 1,883 | 36 d ago |
| Sep 4, 2026 | CBSH COMMERCE BANCSHARES INC /MO/ | Jennifer B Upton Senior Vice President | DDisposition to issuer Common Stock | -148 | $58.52 | $8,661 | 1,735 | 36 d ago |
| Sep 3, 2026 | PFG PRINCIPAL FINANCIAL GROUP INC | Deanna D Strable-Soethout Chair, President and CEO | DDisposition to issuer Common Stock10b5-1 | -55,140 | $120.60 | $6.6M | 173,867 | 37 d ago |
| Sep 4, 2026 | LPSN LIVEPERSON INC | Christopher Allen Mina Chief Tech Product Officer | DDisposition to issuer Common Stock | -9,636 | - | - | 43,000 | 41 d ago |
| Sep 4, 2026 | LPSN LIVEPERSON INC | Christopher Allen Mina Chief Tech Product Officer | DDisposition to issuer Common Stock | -43,000 | - | - | 0 | 41 d ago |
| Sep 4, 2026 | LPSN LIVEPERSON INC | Dan Fletcher director | DDisposition to issuer Common Stock | -18,666 | - | - | 0 | 41 d ago |
| Sep 4, 2026 | LPSN LIVEPERSON INC | Nathan Lane director | DDisposition to issuer Common Stock | -23,350 | - | - | 0 | 41 d ago |
| Sep 4, 2026 | LPSN LIVEPERSON INC | Anthony John Sabino Chief Executive Officer | DDisposition to issuer Common Stock | -37,080 | - | - | 135,271 | 41 d ago |
| Sep 4, 2026 | LPSN LIVEPERSON INC | Anthony John Sabino Chief Executive Officer | DDisposition to issuer Common Stock | -135,271 | - | - | 0 | 41 d ago |
| Sep 4, 2026 | LPSN LIVEPERSON INC | Anthony John Sabino Chief Executive Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -66,666 | - | - | 0 | 41 d ago |
| Sep 4, 2026 | LPSN LIVEPERSON INC | Karin-Joyce Tjon director | DDisposition to issuer Common Stock | -18,666 | - | - | 0 | 41 d ago |
| Sep 4, 2026 | LPSN LIVEPERSON INC | John DeNeen Collins CFO and COO | DDisposition to issuer Common Stock | -27,082 | - | - | 81,148 | 41 d ago |
| Sep 4, 2026 | LPSN LIVEPERSON INC | John DeNeen Collins CFO and COO | DDisposition to issuer Common Stock | -81,148 | - | - | 0 | 41 d ago |
| Sep 4, 2026 | LPSN LIVEPERSON INC | John DeNeen Collins CFO and COO | DDisposition to issuer Stock Option (Right to Buy)derivative | -6,260 | - | - | 0 | 41 d ago |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.